Efficient induction of HIV-1 replication in latently infected cells through contact with CD4+ T cells: involvement of NF-kappaB activation (Q40183372)

18 September 2017

Efficient induction of HIV-1 replication in latently infected cells through contact with CD4+ T cells: involvement of NF-kappaB activation (English)

1 reference

18 September 2017

0 references

9

Naoki Yamamoto

1 reference

18 September 2017

Xiaohua Qi

1

1 reference

18 September 2017

Yoshihiro Koya

2

1 reference

18 September 2017

Tatsuya Saitoh

3

1 reference

18 September 2017

Yasunori Saitoh

4

1 reference

18 September 2017

Saki Shimizu

5

1 reference

18 September 2017

Kenji Ohba

6

1 reference

18 September 2017

Norio Yamamoto

7

1 reference

18 September 2017

Shoji Yamaoka

8

1 reference

18 September 2017

language of work or name

English

0 references

publication date

10 January 2007

1 reference

18 September 2017

1 reference

18 September 2017

361

1 reference

18 September 2017

2

1 reference

18 September 2017

325-334

1 reference

An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses

18 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Functional CD4 T cells after intercellular molecular transfer of 0X40 ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Interaction between chronically HIV-infected promonocytic cells and human umbilical vein endothelial cells: role of proinflammatory cytokines and chemokines in viral expression modulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Costimulatory regulation of T cell function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

In vivo CD40-CD154 (CD40 ligand) interaction induces integrated HIV expression by APC in an HIV-1-transgenic mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Combination therapy with zidovudine, didanosine and saquinavir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Mechanisms for macrophage-mediated HIV-1 induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Human immunodeficiency virus type 1 protease inhibitors block toll-like receptor 2 (TLR2)- and TLR4-Induced NF-kappaB activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Host factors and the pathogenesis of HIV-induced disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

The role of the CD28 receptor during T cell responses to antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Enhancement of HIV replication and giant cell formation by tumor necrosis factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Cytokines and HIV infection: is AIDS a tumor necrosis factor disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Plat-E: an efficient and stable system for transient packaging of retroviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Oscillations in NF-kappaB signaling control the dynamics of gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Aberrant NF-kappaB2/p52 expression in Hodgkin/Reed-Sternberg cells and CD30-transformed rat fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Antitumorigenic effects of HIV protease inhibitor ritonavir: inhibition of Kaposi sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Twenty years of therapy for HIV-1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

OX40 stimulation by gp34/OX40 ligand enhances productive human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.014

10.1016/J.VIROL.2006.11.014

7 January 2021

Identifiers

DOI

1 reference

18 September 2017

1 reference